Better Funding Needed For WHO Prequalification Of Medicines Program, Experts Say

The Guardian: Better funding call for vital drug approval program
In her Global Health Blog for The Guardian, Sarah Boseley discusses a recently published article examining “[t]he prequalification of medicines program (PQP) of the WHO, launched in 2001, [which] was set up to assess the quality of the generic medicines for HIV and other diseases made by companies in India, China and elsewhere. … But, say four respected experts in the Journal of Public Health Policy, the program is endangered by its insecure funding…” (1/15).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.